ClinicalTrials.Veeva
Menu

Find clinical trials for Endometrial Cancer in Birmingham, AL

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Ovarian Cancer
Non-Small-Cell Lung Carcinoma
Breast Cancer
Colorectal Cancer
Cancer
Uterine Cervical Cancer
Stomach Cancer

Endometrial Cancer trials near Birmingham, AL, USA:

Signatera Assessment in Early-Stage Endometrial Cancer (SIGNAL-EMC 101)

The goal of this clinical trial is to assess if circulating tumor DNA can guide adjuvant selection in high-intermediate risk early-stage endometrial...

Begins enrollment this month
Endometrial Cancer
Device: Signatera Genome ultra-sensitive ctDNA blood test
Natera
Natera

Birmingham, Alabama, United States and 11 other locations

This is a single arm, Phase II study using the combination of atezolizumab and bevicacizumab in women with advanced, recurrent or persistent endometrial...

Active, not recruiting
Endometrial Cancer
Drug: Atezolizumab
Drug: Bevacizumab

Phase 2

University of Oklahoma (OU)
University of Oklahoma (OU)

Birmingham, Alabama, United States and 2 other locations

global, multi-arm study to evaluate efficacy and safety of relacorilant in combination with other treatments in patients with gynecological cancers...

Enrolling
Endometrial Cancer
Fallopian Tube Cancer
Drug: Bevacizumab 10 mg/kg
Drug: Nab-paclitaxel 80 mg/m^2

Phase 2

Corcept Therapeutics
Corcept Therapeutics

Birmingham, Alabama, United States and 48 other locations

antitumor activity of IMGN151 in adult participants with recurrent endometrial cancer; recurrent, high-grade serous epithelial ovar...

Active, not recruiting
Endometrial Cancer
Fallopian Tube Cancer
Drug: IMGN151

Phase 1

AbbVie
AbbVie

Birmingham, Alabama, United States and 57 other locations

Locations recently updated

can be given alone or with cemiplimab to patients with ovarian cancer or cancer of the uterus* The study will also look at the leve...

Enrolling
Endometrial Cancer
Recurrent Primary Peritoneal Cancer
Drug: Sarilumab
Drug: Ubamatamab

Phase 1, Phase 2

Regeneron Pharmaceuticals
Regeneron Pharmaceuticals

Birmingham, Alabama, United States and 55 other locations

The purpose of this study is to compare pembrolizumab + adjuvant chemotherapy with placebo + adjuvant chemotherapy, with or without radiotherapy, wit...

Active, not recruiting
Endometrial Neoplasms
Drug: Placebo for pembrolizumab
Drug: Cisplatin

Phase 3

Merck Sharp & Dohme (MSD)
Merck Sharp & Dohme (MSD)

Birmingham, Alabama, United States and 232 other locations

besides treating your disease.Participants will have solid tumor cancer that has spread through the body (metastatic) or cannot be removed w...

Enrolling
Endometrial Cancer
Gastric Cancer
Drug: pembrolizumab
Drug: PF-08046054

Phase 1

Seagen, a wholly owned subsidiary of Pfizer

Birmingham, Alabama, United States and 61 other locations

The objective of this study is to evaluate the safety, tolerability, and efficacy of BL-M07D1 in patients with HER2 expressing advanced tumors.

Enrolling
Endometrial Cancer
Breast Cancer
Drug: BL-M07D1

Phase 1

Systimmune
Systimmune

Birmingham, Alabama, United States and 25 other locations

The main purpose of the study is to assess whether the study drug, LY4066434, is safe and tolerable when administered to participants with locally ad...

Active, not recruiting
Non-small Cell Lung Cancer
Colorectal Cancer
Drug: Pembrolizumab
Drug: Irinotecan

Phase 1

Lilly
Lilly

Birmingham, Alabama, United States and 46 other locations

with the exception of people with advanced non-small cell lung cancer (NSCLC).Solid tumors may have specific changes or mutations to a gene ...

Enrolling
Advanced Solid Tumors
HER2 Mutation
Drug: BAY2927088

Phase 2

Bayer
Bayer

Birmingham, Alabama, United States and 55 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems